Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aquestive Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aquestive Therapeutics Inc
Rating: 1.15733325
Author: Trendlyne DVM scores

about

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

3.52 0.10 (2.92%)

53.38% Fall from 52W High

7.1M

XNAS Volume

High vol.+loss this week

XNAS 14 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

7.3 / 100

Technically Neutral

39.0 / 100

1Yr Price target upside is 145%

8 analysts

Aquestive Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

53.38% Fall from 52W High

High vol.+loss this week

SWOT Analysis

Aquestive Therapeutics Inc Live Price Chart